| Implications of heterogeneity in multiple myeloma S de Mel, SH Lim, ML Tung, WJ Chng BioMed research international 2014 (1), 232546, 2014 | 91 | 2014 |
| Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots ML Tung, B Tan, R Cherian, B Chandra Rheumatology advances in practice 5 (1), rkaa081, 2021 | 65 | 2021 |
| A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore N Ngoi, J Lim, S Ow, WY Jen, M Lee, W Teo, J Ho, R Sundar, ML Tung, ... ELSEVIER, 2020 | 60 | 2020 |
| Retinal ciliopathies through the lens of Bardet-Biedl Syndrome: past, present and future B Chandra, ML Tung, Y Hsu, T Scheetz, VC Sheffield Progress in retinal and eye research 89, 101035, 2022 | 24 | 2022 |
| Necrotizing Fasciitis in Hematological Patients: Enterobacteriaceae Predominance and Limited Utility of Laboratory Risk Indicator for Necrotizing Fasciitis Score RM Foo, ML Tung, LM Poon, D Chan, N Smitasin, LP Koh, WJ Chng, ... Open forum infectious diseases 2 (2), ofv081, 2015 | 19 | 2015 |
| Long term use of metformin leading to vitamin B 12 deficiency ML Tung, LK Tan Diabetes research and clinical practice 104 (3), e75-e76, 2014 | 18 | 2014 |
| COVID-19 conundrum: Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness R Cherian, B Chandra, ML Tung, A Vuylsteke European Respiratory Journal 56 (2), 2020 | 16 | 2020 |
| Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore CW Tan, BE Fan, WZY Teo, ML Tung, H Shafi, D Christopher, S Zheng, ... Thrombosis journal 19, 1-7, 2021 | 15 | 2021 |
| Relationship of JAK2 (V617F) allelic burden with clinico-haematological manifestations of Philadelphia-negative myeloproliferative neoplasms KS Yow, X Liu, CN Chai, ML Tung, B Yan, D Christopher, KH Ong, ... Asian Pacific journal of cancer prevention: APJCP 21 (9), 2805, 2020 | 7 | 2020 |
| Positive bubble study in severe COVID-19 indicates the development of anatomical intrapulmonary shunts in response to microvascular occlusion R Cherian, B Chandra, ML Tung, A Vuylsteke American journal of respiratory and critical care medicine 203 (2), 263-265, 2021 | 6 | 2021 |
| Rethinking COVID-19 ‘pneumonia’–is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine? TT Low, R Cherian, SL Lim, B Chandra, ML Tung, SK Kumar, P Lye, ... Pulmonary circulation 10 (3), 2045894020931702, 2020 | 5 | 2020 |
| Co-occurrence of VHL and SDHA Pathogenic Variants: A Case Report ML Tung, B Chandra, K Dillahunt, MD Gosse, TS Sato, A Sidhu Frontiers in oncology 12, 925582, 2022 | 3 | 2022 |
| CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response ER Westin, A Khodadadi-Jamayran, LK Pham, ML Tung, FD Goldman G3: Genes, Genomes, Genetics 13 (11), jkad207, 2023 | 2 | 2023 |
| Endoscopic and endoscopic ultrasound (EUS) features of annular pancreas: duodenal ulceration and a dilated bile duct EWL Wee, NM Varghese, ML Tung, HC Low Endoscopy 44 (S 02), E417-E418, 2012 | 2 | 2012 |
| Iowa newborn screening program experience with hemoglobinopathy screening over the last two decades and its increasing global relevance R Jilek, J Marcy, C Johnson, G Younger, A Calhoun, ML Tung International Journal of Neonatal Screening 10 (1), 21, 2024 | 1 | 2024 |
| TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis ML Tung, B Chandra, J Kotlarek, M Melo, E Phillippi, CM Justice, A Musolf, ... Genes 13 (9), 1649, 2022 | 1 | 2022 |
| Feasibility of Advanced Practice Nurse-Led Telehealth Service in Patients with Myeloproliferative Neoplasm in the Community: A Singapore Single-Centre Report CC Lim, X Chen, YM Lee, WZY Teo, ML Tung, WJ Chng, M Ooi Blood 136, 18-19, 2020 | 1 | 2020 |
| Epidemiology of patients with classical Philadelphia-chromosome negative myeloproliferative neoplasms at a single academic medical Center in Singapore PS Chia, VCL Chong, TY Tay, ES Yap, WJ Chng, X Liu, ML Tung Blood 132, 5478, 2018 | 1 | 2018 |
| ASXL1 As a Potential Genetic Modifier in a Family with GATA2 Deficiency M VanDerGraaf, K Dillahunt, G Younger, DK Bayer, M Halyko, ... Blood 144, 5711, 2024 | | 2024 |
| P145: Paradigm shift in Occam’s Razor and the need for genotype driven reverse phenotyping in rare diseases with complex phenotypes ML Tung, B Chandra, J Nagy, H El-Shanti, J Bernat, N Safina, A Calhoun, ... Genetics in Medicine Open 2, 101042, 2024 | | 2024 |
